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ABSTRACT
Introduction: Chronic musculoskeletal pain is a
common condition that often responds poorly to
treatment. Self-management courses have been
advocated as a non-drug pain management
technique, although evidence for their effectiveness
is equivocal. We designed and piloted a
self-management course based on evidence for
effectiveness for specific course components and
characteristics.
Methods/analysis: COPERS (coping with persistent
pain, effectiveness research into self-management) is
a pragmatic randomised controlled trial testing the
effectiveness and cost-effectiveness of an intensive,
group, cognitive behavioural-based, theoretically
informed and manualised self-management course
for chronic pain patients against a control of best
usual care: a pain education booklet and a relaxation
CD. The course lasts for 15 h, spread over 3 days,
with a –2 h follow-up session 2 weeks later. We aim
to recruit 685 participants with chronic
musculoskeletal pain from primary, intermediate and
secondary care services in two UK regions. The
study is powered to show a standardised mean
difference of 0.3 in the primary outcome, pain-related
disability. Secondary outcomes include generic
health-related quality of life, healthcare utilisation,
pain self-efficacy, coping, depression, anxiety and
social engagement. Outcomes are measured at 6 and
12 months postrandomisation. Pain self-efficacy is
measured at 3 months to assess whether change
mediates clinical effect.
Ethics/dissemination: Ethics approval was given
by Cambridgeshire Ethics 11/EE/046. This trial will
provide robust data on the effectiveness and
cost-effectiveness of an evidence-based, group
self-management programme for chronic
musculoskeletal pain. The published outcomes will
help to inform future policy and practice around such
self-management courses, both nationally and
internationally.
Trial registration: ISRCTN24426731.
BACKGROUND
Chronic conditions, especially musculoskel-
etal conditions, impose an increasing burden
on healthcare systems and society.1 Point esti-
mates of the prevalence of chronic musculo-
skeletal pain (pain lasting for longer than
the normal soft tissue healing time of
around 12 weeks2) range from 46% to 76%.3
In 2008, the annual report on public health
of the UK Chief Medical Officer identified
chronic pain as a major issue which needed
to be addressed.4 Despite increased under-
standing of the factors contributing to the
development of chronic pain,5 there has
been little improvement in how successfully
it is treated and managed.6 Current
ARTICLE SUMMARY
Article focus
▪ We outline all procedures for a pragmatic trial
investigating the effectiveness of a self-manage-
ment intervention for chronic musculoskeletal
pain.
Key messages
▪ Complex interventions need to be based on
evidence and have good theoretical underpinning.
▪ The value of pilot studies cannot be
underestimated.
▪ Identifying patients with non-electronically indexed
conditions is difficult.
Strengths and limitations of this study
▪ This is a complex intervention with good theoret-
ical underpinnings
▪ The trial protocol was informed comprehensive
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▪ Difficulties surround the identification patients
with non-electronically indexed conditions such
as chronic pain.
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treatment tends to centre on drug regimens for pain
control and depression, physiotherapy and pain-
management programmes. However, many patients will
experience complex care pathways involving multiple
referrals to secondary care and often unnecessary and
repeated diagnostic tests.7
Several UK Department of Health reports have recom-
mended self-care for chronic disease as a strategy for
improving the long-term future of health in the UK.8–10
Since 2000, the UK has invested in the implementation
of lay-led (ie, peer-led) self-management training
courses, the Expert Patients Programme (EPP).10 The
available evidence, however, suggests that these courses
may not reduce healthcare resource use as expected 11–13
and that there are only modest short-term beneficial
effects on other outcomes. Very few studies have exam-
ined the long-term clinical effects.13–15
In response to the anomaly between continued UK gov-
ernment support of self-management programmes and
equivocal evidence of their effectiveness, the COPERS
(coping with persistent pain, effectiveness research into
self-management) study (http://blizard.qmul.ac.uk/
research-generation/329-copers.html) was commissioned
by the National Institute of Health Research (NIHR), as a
5-year programme grant to identify which components and
characteristics of self-management and pain-management
programmes are the most effective, as well as to evaluate
these components in a trial, in order to inform both the
development of a new pain self-management course and
the next generation of self-management courses in
general. We completed two systematic reviews and a qualita-
tive study that informed the development of the COPERS
intervention. One review collated the evidence base
for components and characteristics of pain and self-
management courses and the other collated the evidence
for predictors, mediators and moderators of outcomes in
these programmes.16 17 In a qualitative study, we explored
the views and experiences of participants and tutors from
self-management courses about expectations, course
content, recruitment, tutoring and attendance.18 The find-
ings from this work suggested that the group-delivered
courses led by healthcare professionals and/or lay people
were most likely to be effective. We also found that courses
lasting for a shorter time appeared to be as effective as
longer courses and that the setting in which courses were
delivered (ie, in healthcare settings or the community)
appeared to make little difference to any beneficial effects.
Evidence also suggested that participants particularly
enjoyed the relaxation elements of courses but were averse
to exercise being included.
Our systematic reviews found evidence to support psy-
chological approaches; therefore, we based our course
around concepts from cognitive behavioural therapy and
acceptance and commitment therapy.19 20 Some ele-
ments of the COPERS intervention are similar to the
EPP, such as the inclusion of relaxation, goal-setting and
action-planning and improving consultations with
healthcare professionals. We also included sessions
related to improving posture and social activities, for
example, art and massage. Self-efficacy has been
reported as an important mediator for success in these
types of ‘treatment’ approaches.21 Since healthcare pro-
fessionals and lay tutors have both been reported as
effective facilitators for self-management programmes,
we used both.22 23 There is mixed evidence for the
optimal duration of self-management courses and ‘dose’
per week. Short weekly sessions over 6 weeks or more
are the usual model, but attendance can be poor.14
However, evidence from mental health research shows
that brief/intensive interventions can be effective and
are often preferred.24 25 The COPERS course is deliv-
ered as a 3-day intensive course on consecutive days, the
rationale being to address the high attrition often
reported anecdotally in other programmes.14
The protocol has been designed as a result of a feasi-
bility study which enabled us to modify our approach to
recruitment, intervention and to test a variety of
outcome measures. Recruitment was problematic in the
feasibility study as there is no specific electronic diagnos-
tic code for chronic pain. We have since piloted a search
strategy based on repeat prescriptions, ‘Read’ codes and
frequency of visits, which identify many of our target
population. To optimise recruitment, we decided to also
use face-to-face consultations and self-referral via adver-
tisements in surgeries and clinics. We found that filling
courses within a set time period was difficult especially
when, by chance, the majority of participants were ran-
domised to the control. We have accommodated this by
using randomly varied permuted block randomisation
and phasing the recruitment of patients to specific time
periods between school holidays.
We convened a focus group consisting of two experts in
outcome measures, two general practitioners (GPs), two
psychologists and two patients with chronic pain. This
focus group selected the most appropriate measures to
test in the pilot trial. In addition to piloting quantitative
data collection, we evaluated the intervention thoroughly
during the pilot study using feedback from observers, par-
ticipants and facilitators. The pilot study indicated that
the COPERS self-management course was viable and well
received by participants, with good attendance (85% full
attendance). We found that the quality of facilitation was
a key determinant for the success of a course and
invested more time and resources in facilitator training
and recruitment for the main trial. Additionally, we
found that the group nature of the course was valued
highly by participants; therefore, we allowed for more
socialising during the intervention.
Aims of the study
The aim of this study is to establish the effectiveness and
cost-effectiveness of the new self-management (COPERS)
course for those with chronic musculoskeletal pain, when
compared with usual care plus a CD recording of simple
relaxation exercises (also received by the intervention
arm via the self-management course).
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Trial purpose
This trial will provide the data needed by the National
Health Service (NHS) purchasers to decide whether or
not to fund programmes of this nature.
METHODS/DESIGN
Trial design
A multicentre pragmatic randomised controlled trial
(RCT) was conducted in the UK with unbalanced ran-
domisation (1.33: 1) (intervention:control) to accommo-
date for the effects of clustering. The unbalanced
randomisation may also improve recruitment; if partici-
pants are told that they are more likely to receive the
active treatment, then they may be more likely to join
the study.
Trial setting
The trial is based in northeast London, and in the
Coventry and Warwickshire region. Participants are
recruited from primary and secondary care settings,
such as general practices, musculoskeletal physiotherapy
units and pain clinics. The population of these two local-
ities, taken together, is broadly representative of the UK
as a whole.
Target population
Inclusion criteria
▸ People aged 18 or over with chronic musculoskeletal
pain of more than 3 months.2 This includes pain
from osteoarthritis and fibromyalgia or chronic wide-
spread pain.
Exclusion criteria
▸ Inability to give informed consent
▸ Not fluent in English
▸ Chronic pain arising from active malignant disease
▸ Pain from inflammatory arthritis, such as rheumatoid
arthritis
▸ Serious active comorbidity or terminal illness
▸ Serious mental health or substance abuse issues
which render the individual unable to attend the
course.
Participant recruitment
Participants are recruited from primary and secondary
care using three methods.
Our main method of recruitment will be bulk mail outs
from targeted searches of the secondary care clinic and
general practice electronic records. Electronic records are
searched by identified key liaison staff in the practices and
clinics. These personnel use a generic search strategy devel-
oped and tested by the study team. The search strategy has
a tiered approach focusing on demographic data (patient
registered at the practice, alive and >18 years old), repeat
prescriptions for analgesics, tricyclic antidepressants and
anxiolytics, followed by clinical symptoms (eg, low-back
pain, back pain, osteoarthritis, fibromyalgia) and
attendance in the previous 3-month period. During pilot
testing, these searches identified 5–7% of general practi-
tioners as possibly eligible and roughly identified our
target population in general practices.
The list of potential participants identified via elec-
tronic search is screened by clinicians at the practice or
clinic to check suitability based on the eligibility criteria.
Eligible patients are invited to join the study by letter
from their GP or secondary care clinic. They are asked
to complete an expression of interest form to send to
the study team or to contact the study team directly.
Clinicians working in participating practices are also
able to invite patients consulting with chronic pain to
participate by handing them an information pack.
Finally, advertisements and invitation packs will be
placed in general practice and clinic waiting rooms to
attract interested patients, who can contact the study
team directly for further information.
Recruitment and informed consent
People expressing an interest in the study, who are eli-
gible and available to participate, are sent a baseline
questionnaire, a trial consent form to complete and a
freepost envelope to return the questionnaire and trial
consent form to the study team. All participants are
telephoned and asked whether they need more infor-
mation, and the consent form is discussed before a
member of the study team counter signs the consent
form indicating informed consent. A summary of partici-
pant flow through the study is shown in figure 1.
Intervention group
The intervention is a group-based, facilitated learning
course supporting patients to manage their chronic pain
better. It is a complex intervention using psychological
approaches which have been shown to promote behav-
iour change of proven benefit in low back pain.26–28 The
course also includes pain education, attention control,
relaxation and visualisation techniques, social interaction
and the opportunity to try a new activity unrelated to
pain (table 1). Teaching and learning methods include
facilitated learning through group discussion, sharing
narratives and experiences to foster social interaction,
problem solving, an educational DVD, role play, practis-
ing attention and distraction techniques and ‘good’
posture. We hypothesise that these group-delivered
courses with plenty of breaks for social interaction will
build confidence to manage chronic pain better, that is,
improve self-efficacy, improve social integration and,
where necessary, help re-activate participants to
re-engage in social activities.29 30 The intervention con-
sists of a short course run in 1 week over 3 days (typically
Monday, Wednesday and Friday) during school hours
(10:00—14:45), with a 2 h follow-up session 2 weeks
later. The total course comprises 24 individual ‘compo-
nents’ spread over 15–16 h. A detailed training manual
for facilitators was developed, tested and refined in the
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pilot study. The manual provides the aims and theoret-
ical basis for each component.
In the absence of any evidence favouring a particular
setting for such group self-management courses, courses
are held in local medical or community venues that are
accessible to participants (eg, with disabled parking and
near to public transport).
Recruitment of facilitators for the intervention
Each course is led by two facilitators, a healthcare
professional (a professionally registered physiotherapist,
osteopath, chiropractor, occupational health practitioner
or psychologist) and a lay person with experience of
both living with chronic pain and of tutoring or facilitat-
ing small groups.
Healthcare professional facilitators are recruited via
press releases about the study in professional magazines.
Lay facilitators are recruited via local contacts with com-
munity interest companies delivering self-management
type programmes (typically the Expert Patient
Programme, http://www.expertpatients.co.uk).
Training facilitators
Facilitators attend a 2-day training course that covers the
course content, how to facilitate, dealing with difficult
situations and what to do if an adverse event occurs.
During the courses, the trainee facilitators are required
to demonstrate actively that they are good listeners,
empathic, flexible, able to encourage equal participation
and laughter, able to manage difficult people, and able
to introduce, lead and summarise sessions while putting
the course content into a chronic pain context. We also
assess their understanding of the course via a written
assessment at the end of the training.
Only facilitators who are assessed as competent (ie,
demonstrate the skills required during role plays and
provide written answers that illustrate an understanding
of the key concepts) will deliver the intervention. They
are to be paired with trained and experienced facilita-
tors from the pilot study for their first course to ensure
consistency of delivery and to promote confidence in
the newly trained facilitators.
Control group
In our pilot study, we found that a usual care control
arm was insufficient to encourage participation in the
trial. Our interviews and pilot studies suggested that par-
ticipants particularly enjoyed the relaxation part of the
courses, while our systematic review found little evidence
that the relaxation component of pain-management
courses had much observable beneficial effect. In this
trial, we include a ‘relaxation pack’ as the control inter-
vention to make participation more appealing. This
includes a simple audio CD of three breathing and
relaxation sequences, instructions and the rationale
behind them. The CD is also used and distributed on
the COPERS course. After randomisation, participants
in the control group receive the relaxation pack and are
asked to practise relaxation at least once a day every day
for 3 weeks (the same duration as the intervention) and
as often as they like thereafter.
In an attempt to ensure that all the study participants
receive best usual care, they are also given a copy of a
booklet, called the ‘The Pain Toolkit’,31 which is pub-
lished by the UK Department of Health and freely dis-
tributed to UK GPs to give to any patient with chronic
pain.
Hypothesis
We hypothesised that the benefits of the intervention
will be improved function, greater self-confidence,
Figure 1 Flow diagram of the study.
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better coping skills, increased social engagement and
more appropriate healthcare resource use (table 2).
Our outcome measures reflect these domains.
Outcomes
For the main trial, we selected a group of measures
based on both the published literature regarding their
Table 1 Outline of the course and theoretical models
Day Sessions Module aims Theory
1 1: Introduction
2: Pain education DVD
3: Acceptance: the uninvited
guest
Understanding pain and acceptance Acceptance and Commitment
Therapy19 45
Lunch break
Taster activity (eg, art) Distract from pain perception with physical activity Attention and distraction
4: Pain, when is it bearable
and when is it not?
Pain is not just physiological; it is a psychological,
emotional and social phenomenon
Biopsychosocial model of
medicine46
5: The pain cycle Recognising the pain cycle and signposting ways
out
Fear avoidance and
catastrophising47
6: Movement and posture
7: Breathing and relaxation
(CD track 1)
Reduce muscle tension to ease pain and become
aware of physical weakness and strengthen areas
Physical therapy principles
and Alexander technique,
biofeedback
2 8: Reflections from day one Improve social bonding, group cohesion and
community social support
Social cognitive theory,30 48
social learning theory29
9: Identifying problems, goal
setting and action planning
10: Barriers to change—
unhelpful thinking
Recognising errors in thinking in order to promote
a constructive/rational view of a situation
Cognitive therapy,20 49
theories of reasoned action
and planned behaviour,50–52
rational emotive therapy53
Lunch break
Taster activity (eg,, art) Distract from pain perception with physical activity Attention and distraction
11: Barriers to change—
reframing negatives to
positives
Recognising errors in thinking in order to promote
a constructive/rational view of a situation
Cognitive therapy20 49 and
theories of reasoned action
and planned behaviour 50–52
12: Attention control and
distraction
Distract from pain perception using visualisation Attention control54
13: Identifying things that
make pain more manageable
Reminders to apply techniques as coping
strategies
Embedding learning
14: Movement and balance
15: Breathing, relaxation and
visualisation
(CD track 2)
Reduce muscle tension to ease pain, become
aware of physical weakness and strengthen areas.
Distraction from pain perception using visualisation
Physical therapy principles
and attention management54
3 16: Reflections from day 2 Improve social bonding, group cohesion and
community social support
Social cognitive theory30 48
17: Communication with
health professionals
18: Listening skills
Promote constructive healthcare consultations and
effective communication
Theories of reasoned action
and planned behaviour 50–52
and Social cognitive
theory30 48
19: Anger, irritability and
frustration
Recognising errors in thinking in order to promote
a constructive/rational view of a situation
Cognitive therapy20 49
theories of reasoned action
and planned behaviour 50–52
Lunch break
Taster activity (eg, art) Distract from pain perception with physical activity Attention management
20: Movement and stretch
21: Breathing, relaxation and
mindfulness
(CD track 3)
Reduce muscle tension to ease pain, become
aware of physical weakness and strengthen areas.
Distraction from pain perception using mindfulness
Physical therapy principles
and attention management54
22: Summing up Reminders to apply techniques as coping
strategies
Embedding learning
Follow-up 23: Reflections and narratives Improve social bonding, group cohesion and
community social support
Social cognitive theory30 48
24: Managing setbacks Reminders to apply techniques as coping
strategies
Embedding learning
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validity and reliability and the extent of their use in
other studies and on the focus group and pilot study.
Primary outcome
Our primary outcome is pain-related disability (we are
not aiming to change pain severity in the short term, as
current understanding of the mechanism of chronic
pain suggests that it is unlikely to improve rapidly).32 To
measure function, we chose a well-validated tool, the
Chronic Pain Grade (CPG).33 The CPG is made up of
two constructs—pain intensity and pain-related disability.
Each construct has been validated separately. They are
scored independently and can be combined to produce
the Chronic Pain Grade.34 Our primary outcome is pain-
related disability. This measure has three questions about
pain-related function, and the responder rates their cir-
cumstance on a scale from 0 to 10. The pain-related dis-
ability score is the mean of the three questions.
Since there is a paucity of evidence on the long-term
effectiveness of these types of interventions,14 we will
measure outcomes by a patient-completed postal ques-
tionnaire at baseline (before randomisation) and at 6
and 12 months after randomisation. There will be one
postal reminder for each follow-up data collection point,
after which non-responders will be contacted by phone
to obtain the primary outcome and quality of life
measures. To encourage completion and return of
questionnaires, we will send participants a £5 ‘high-street
shop’ voucher redeemable in multiple stores on a non-
conditional basis along with their 6-month and
12-month questionnaires. This expression of appreci-
ation has been shown to improve questionnaire return
rates. A Cochrane review has found that ‘the odds of
response’ were more than doubled when a monetary
incentive was used (OR 2.02; 95% CI 1.79 to 2.27) and
almost doubled when incentives were not conditional on
response (1.71; 1.29 to 2.26).35
Secondary outcomes
Table 2 shows our secondary outcomes.
Criteria for withdrawal
All participants are free to withdraw from the study at
any time without having to give any explanation.
Sample size
The sample size calculation was based on detecting a
standardised mean difference of 0.3 in pain-related dis-
ability between the intervention and control groups,
with a power of 80% at the 5% significance level. This
effect size is commensurate with the largest change seen
in a recent systematic review of expert patient pro-
grammes,14 and also with the sort of change effected by
interventions for other chronic pain syndromes, such as
low back pain, on any continuous outcome measure.36
A simple sample size calculation indicates that we would
require data on 350 subjects. We inflated the sample size
because of the possibility of a ‘clustering’ effect in the
group intervention arm and chose the ratio between
intervention and control participants to increase statis-
tical efficiency.37 Using an intracluster correlation coeffi-
cient of 0.1 and assuming, on average, 9 individuals
providing data from each group resulted in 480 indivi-
duals being needed with 275 in the intervention group
and 205 in the control group (1.33:1 intervention:
control). Allowing, conservatively, for a 30% loss to
follow-up (from an average of 13 individuals recruited
per group), we sought to randomise 685 participants
(391 intervention participants and 294 controls).
Table 2 Outcome measures and other data collection
Domain Measures
Follow-up
(months)*
Pain duration Numerical scale 0
Pain intensity Chronic Pain Grade (pain intensity subscale)33 0, 6, 12
Pain disability Chronic Pain Grade (pain disability subscale)33 0, 6, 12
Quality of Life EQ-5D (health utility)55 0, 6, 12
Self-efficacy Pain Self-Efficacy Questionnaire56 0, 3, 6, 12
Mood Hospital Anxiety and Depression Scale57 0, 6, 12
Coping Chronic Pain Acceptance Questionnaire58 0, 6, 12
Social activity HEIQ (Social integration subscale)59 0, 6, 12
General Health Census global health question60 0, 6, 12
Demographics Age, NHS number, sex, ethnicity, educational background, employment status,
language fluency, living arrangements (alone or with others)
0
Economic
analysis
Healthcare resource use: primary care consultations, secondary care consultations,
hospital admissions, surgeries, imaging, tests and prescriptions from general practice
electronic records
0 to 12
Comorbidities From general practice electronic records according to the Cumulative Illness Rating
Scale7
12
*Postrandomisation.
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Previous research and electronic record searches from
the pilot study indicated that around 5% of adults on
GP registers consult with chronic musculoskeletal pain.
Of these, based on our pilot study, we estimate that 10%
may be interested in participating in the trial and
around half of these will be recruited into the trial.
We estimated that around 80% of the population are
adults over 18 years of age (www.statistics.gov.uk 2010).
This means that to recruit our 685 participants, we
needed a population base of around 342 000 (342 000
registered patients of whom approximately 80% are
adults (274 000). Five per cent of these may have
chronic pain (13 700), and of these, we estimate that
around 10% may express interest in the study (1370).
Half of these may be recruited and enrolled (685).
Using an average, total GP list size of 7000, this equates
to around 49 practices. We estimate that we will recruit
between 12 and 14 patients per practice.
This may be an overestimate of the number of prac-
tices needed as it does not account for participants
recruited from pain or musculoskeletal physiotherapy
clinics or from face-to-face invitations and advertise-
ments within general practices. After signing up to the
study, general practices are given a choice of recruitment
phases corresponding to blocks of prebooked course
dates. Recruitment will be split roughly equally between
each of our study sites.
We are aiming to book participants into courses within
12 weeks of randomisation. The minimum course size is
nine, due to the cost implications of running more
courses. If a course is undersubscribed (<9) at the
outset, it is either cancelled and those registered offered
alternative dates for other courses, or those from other
courses will be transferred to the more imminent
courses where possible.
Randomisation
The randomisation plan was developed by the Pragmatic
Clinical Trials Unit (PCTU) at Queen Mary, University
of London (http://blizard.qmul.ac.uk/pragmatic-
clinical-trials-unit.html). Randomisation was stratified by
centre (the Midlands or London). To ensure that alloca-
tion provides sufficient participants for each course, but
which cannot be predicted by researchers, we used ran-
domly varied permuted blocks of size 7 and 14 with an
allocation ratio of 1.33:1 (intervention:control). Those
returning completed questionnaires were telephoned
by the study team. People who were able and willing to
participate and gave valid informed consent were rando-
mised over the phone. During the phone call, research-
ers entered the participant’s trial identification number
and recruiting centre into a central randomisation
service, ensuring allocation concealment and partici-
pants received immediate notification of their allocation.
Participants are then informed and either immediately
booked on a course or sent a relaxation pack.
Blinding and protection from bias
All baseline data are collected by self-completed question-
naire prior to randomisation. After allocation, however, it
is impossible to blind researchers and patients to alloca-
tion due to the nature of the intervention and the
unequal randomisation. In compliance with our research
ethics committee requirements, GPs are informed of
their patient’s enrolment into the trial but not of their
allocation. Although participants are free to divulge this
information to their primary care team, we feel this infor-
mation in itself should have little impact on their care.
Outcome data are by patient completed postal question-
naire. For non-responders, primary outcome data and
the Euroqol instrument are collected over the phone by
research personnel blind to treatment allocation who use
a set script asking participants not to divulge their alloca-
tion prior to asking them for their data.
Data management
All data are managed in line with PCTU standard oper-
ating procedures and subject to review by audit and the
Data Monitoring and Ethics Committee (DMEC). All
electronic participant data are stored in encrypted and/
or password-protected files in a secure environment. A
database has been designed to manage the data input to
ensure consistency of practice and coding, with a built-in
audit trail enabling us to track all entries and changes.
Regular audit and double-checking of all primary out-
comes will be conducted to ensure accuracy of data
input, and a further random 10% of all data entry will
be double-checked.
Adverse event reporting
These are reported via the facilitators. Minor adverse
incidents (eg, a participant being tearful and distressed
during a session) are logged and fed back to the study
team by the end of the course. Serious adverse events
related to the study (eg, extreme distress or expressing
suicidal thoughts) are reported immediately to the study
principal investigator in accordance with good clinical
practice guidelines and, where necessary, reported to
the DMEC and the study sponsor.
Statistical analysis
We will use Stata,37 R38 and MLwiN,39 as appropriate, to
analyse the data. Descriptive statistics will be used to
summarise the characteristics of participants in each
arm of the trial. Outcomes at follow-up will be analysed
as dependent variables in mixed effects regression
models. The model will include as covariates: baseline
outcome measure, allocation (intervention or control),
age, gender, study centre (London or the Midlands) as
fixed effects, and the intervention group as a random
effect. Where participants withdraw, we will compare the
characteristics of those withdrawing against those who
remain in the study.
Our primary analysis is an available case analysis
following the intention-to-treat principles (http://
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www.consort-statement.org/consort-statement/further-
explanations/box6_intention-to-treat-analysis/). We will
use mixed effects models appropriate for each outcome
(linear, logistic, Poisson) with intervention arm, age and
gender and baseline level of outcome as fixed effects
and group as a random effect. The random effect will
only be present in the intervention arm. We will
examine patterns of ‘missingness’ and conduct a second-
ary analysis using multiple imputation and assuming
variables are missing at random. We will also conduct a
complier-average causal effect analysis to estimate the
effect of the intervention on compliers.40 We define
‘compliers’ as those who attend more than half of the
course (ie, those present for at least 12 of the 24 course
components). We are also interested in the dose inter-
vention participants receive, and define ‘full’ exposure
to the intervention as being present at 17– 24 individual
course sessions, moderate exposure as being present at 9
–16 components, and non-exposure as being present at
eight or fewer components. We will report effect esti-
mates with CIs. For selected outcomes, we will estimate
the proportions who improve over the threshold of 30%
from baseline, a figure commonly used in relation to
back pain, and from this, we will estimate the numbers
needed to be treated and the relative risks for improve-
ment.36 If the analysis shows an effect of the interven-
tion on our primary outcome (pain-related disability),
we will conduct an exploratory analysis to explore
whether any of the following are moderators of the
effect: baseline duration of chronic pain, severity of
pain-related disability and pain self-efficacy. We will also
conduct a mediator analysis to determine whether the
level of exposure to the intervention or a positive
change in self-efficacy from baseline to 12 weeks postran-
domisation mediates the effects at 6 or 12 months.
Health economic analysis
At 12 months postrandomisation, we will conduct a
cost-utility analysis using EQ-5D data to measure Quality
Adjusted Life years (QALYs) from an NHS perspective.
The costs will cover primary care services, prescribed medi-
cation, investigations, intermediate care referrals and sec-
ondary care (using secondary user services (SUS) data).
Primary care services include consultations with GPs and
practice nurses, both scheduled and unscheduled.
Intermediate care referrals data will be collected on
physiotherapy, mental health services (including Improved
Access to Psychological Therapies referrals), podiatry,
community nursing, community rehabilitation and other
unscheduled primary or community care (out-of-hours
services and walk-in centres). SUS will include accident
and emergency visits, outpatient appointments and
inpatient episodes. The SUS data will have International
Classification of Disease 10 and Office of Population
Censuses and Surveys codes which will provide informa-
tion about disease and billing data. Information derived
from the Office for National Statistics death reports will be
the filter for attrition by death, as the cause of death is
included in this information. A secondary analysis will
include broader societal costs such as the patients’
out-of-pocket treatments for their pain such as comple-
mentary therapies, mobility devices, private investigations
and private hospital admissions.
The data will be collected from three main sources:
primary care utilisation from GP electronic records at
12 months’ follow-up, SUS data from the local strategic
health bodies at 15 months (since there is a 3- month
‘lag’ in the availability of SUS data) and patient-reported
cost and utility data from the 6-month and 12-month
questionnaires. Data on the costs of training sessions will
be collected from trial records. Primary and intermedi-
ate care unit costs will be derived from UK published
sources.41 The unit costs for medications will be
obtained from the Prescription Cost Analysis database
for 2010.42 The unit costs for secondary care will be
based on health resource groups.43
If appropriate, we will use multiple imputation to
guard against any bias that may result from missing
EQ-5D or cost data. The imputation model will impute
missing data based on age, gender, study centre
(London or the Midlands), EQ-5D and cost. The imput-
ation model for the intervention arm will also account
for clustering by group in the intervention arm (by
including the intervention group as a random effect).
Our primary economic analysis is a cost-utility analysis
over 12 months, examining the cost per QALY gained
for all participants who were assessed for EQ-5D prior to
randomisation and had SUS data extracts. Descriptive
statistics will be used to summarise the costs and QALYs.
We will use a mixed effects regression model to adjust
estimates for costs and QALYs for the following covari-
ates: baseline outcome measure, allocation (intervention
or control), age, gender, study centre (London or the
Midlands) as fixed effects, and the intervention group as
a random effect. The Incremental Cost Effectiveness
Ratio (ICER) will be calculated using the QALYs for
each patient as a utility measurement along with the
costs to the NHS incurred by each patient, where:
ICER ¼ ðCost of intervention  Cost of controlÞ
Utility of intervention Utility of control
The spread of the incremental cost-effectiveness ratio
across the four quadrants of cost effectiveness will be
plotted, and we will use bootstrapping to estimate the
CIs of our estimates. We also plan to assess the cost
utility of the intervention using willingness to pay thresh-
olds ranging between £0 and £40 00044 and to run two
sensitivity analyses:
1. Excluding high-cost individuals (top 5%).
2. Including costs from the societal perspective (out-of-
pocket treatments for pain).
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Quality control and fidelity of intervention delivery
The first day of each course is observed, and where we
have first time facilitators, or facilitators who lack confi-
dence, these courses are observed in their entirety to
check the fidelity of the intervention. In addition, every
course is audiorecorded. A random selection of audio-
taped sessions will be chosen for evaluation of fidelity.
The evaluators will use a checklist to record adherence
to structure and content and facilitator competence.
Feedback to facilitators will be provided, where neces-
sary, so they can modify and improve their performance.
CONCLUSION
This definitive trial will provide robust data on the effect-
iveness and cost-effectiveness of an optimised package of
care designed to improve self-management of chronic
pain. This will help to serve to inform future policy and
practice for running self-management courses both
nationally and internationally.
Trial status
We anticipate that our results will be complete and sub-
mitted for peer review publication in January 2014.
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